BioLife Solutions, Inc.BLFSNASDAQ
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank46
3Y CAGR-88.2%
Year-over-Year Change
Year-over-year free cash flow growth rate
3Y CAGR
-88.2%/yr
vs -11.8%/yr prior
Acceleration
-76.5pp
Decelerating
Percentile
P46
Within normal range
vs 3Y Ago
0x
Contraction
Streak
1 qtr
Consecutive growthRecovering
| Period | Value |
|---|---|
| Q4 2025 | 0.75% |
| Q3 2025 | -50.19% |
| Q2 2025 | 262.44% |
| Q1 2025 | 166.21% |
| Q4 2024 | -84.19% |
| Q3 2024 | -32.50% |
| Q2 2024 | 213.10% |
| Q1 2024 | -463.23% |
| Q4 2023 | 122.64% |
| Q3 2023 | 29.45% |
| Q2 2023 | -38.62% |
| Q1 2023 | -276.26% |
| Q4 2022 | 458.74% |
| Q3 2022 | 92.05% |
| Q2 2022 | -27.42% |
| Q1 2022 | -263.14% |
| Q4 2021 | -685.11% |
| Q3 2021 | 96.62% |
| Q2 2021 | -1602.27% |
| Q1 2021 | 65.04% |
| Q4 2020 | -45.94% |
| Q3 2020 | -127.35% |
| Q2 2020 | 657.49% |
| Q1 2020 | 140.92% |
| Q4 2019 | -226.15% |
| Q3 2019 | 688.76% |
| Q2 2019 | -117.98% |
| Q1 2019 | 133.19% |
| Q4 2018 | -20.14% |
| Q3 2018 | -1.75% |
| Q2 2018 | 54.26% |
| Q1 2018 | -53.28% |
| Q4 2017 | 1128.20% |
| Q3 2017 | 142.46% |
| Q2 2017 | 30.29% |
| Q1 2017 | 77.98% |
| Q4 2016 | 12.92% |
| Q3 2016 | 22.89% |
| Q2 2016 | 35.73% |
| Q1 2016 | -28.65% |